We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





MEDLAB Europe 2018 Presents Latest Technologies and Developments

By LabMedica International staff writers
Posted on 04 Oct 2018
MEDLAB Europe 2018, which took place in Barcelona, Spain, from October 2-4, 2018, featured over 150 exhibitors showcasing the latest cutting-edge technologies and recent developments in the medical laboratory industry. More...
The second edition of the show welcomed more than 2,600 international visitors and delegates, offering international manufacturers a chance to network with over 1,000 medical dealers and distributors from Spain, Italy, France, Germany, Portugal and other countries.

Alongside the exhibition, the show hosted multi-disciplinary CME-accredited conferences over three days that covered a range of topics, including Point of Care Testing (POCT), immunology, laboratory management anatomic pathology, clinical microbiology and hematology. The conferences tackled current challenges and developments key to the European laboratory and diagnostics market. These areas included the latest in clinical diagnostics development to review the expanding role of laboratory medicine and discuss the key aspects in improving overall patience care and delivery, from new methods of effective lab management to the development of techniques in detecting diseases. This provided an opportunity to learn about advances in science and their applications in laboratory medicine that will improve practice through improving patient outcomes.

The show also hosted free-to-attend workshops in Spanish designed specifically for laboratory technicians, covering topics such as automation, next-generation sequencing and mass spectrometry.



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
New
Silver Member
Urine Test Strips
LabStrip U12 mALB/CREA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Pathology

view channel
Image: The new methyl-copying PCR method preserves DNA methylation patterns during amplification (Photo courtesy of Syndex Bio)

Novel mcPCR Technology to Transform Testing of Clinical Samples

DNA methylation is an important biological marker used in the diagnosis and monitoring of many diseases, including cancer. These chemical modifications to DNA influence gene activity and can reveal early... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.